Studies have reported that VASH2 is able to promote tumor growth by accelerating angiogenesis in various cancers, including breast cancer [8], liver cancer [9], ovarian cancer [10], and gastrointestinal cancer [11]. This evidence concerns the gene VASH2 and cancer.